Sparlon Risk Management Plan For Serious Skin Reactions To Be Discussed By Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
During review, FDA staff disagrees about significance and implications of serious skin reactions and other adverse events with Sparlon.